Urokinase-type plasminogen activator is a strong plasminogen activator which specifically cleaves the proenzyme/zymogen plasminogen to form the active enzyme plasmin. It specifically catalyzes the cleavage of the arg-|-val bond in plasminogen. The active plasmin is then able to break down the fibrin polymers of blood clots. Clinically, urokinase-type plasminogen activator is given to patients suffering from thrombolytic disorders.
The amino terminal fragment (ATF) of urokinase-type plasminogen activator is 130 amino acid residues long. It consists of 2 alpha-helices (green) and 2 antiparallel beta-strands (purple). The ATF contains 2 domains; a growth factor domain and a kringle domain. It binds fucose (magenta) as a ligand.
| Product | Method/Application | Packaging | CAT # |
|---|---|---|---|
| u-PA 4UK IgG | Antibody | 500 micrograms | TC21063 |
| u-PA 5UK | Antibody | 500 micrograms | TC21073 |
| Rabbit u-PA | Antibody | 1 mg | TC31014 |
| Rabbit u-PA | Antibody | 5 mg | TC31015 |
| scu-PA 35scu-PA | Antibody | 500 micrograms | TC21283 |
| scu-PA 14scu-PA | Antibody | 500 micrograms | TC21293 |
| scu-PA PUK | Antibody | 500 micrograms | TC21383 |
| scu-PA 1scu-PA | Antibody | 500 micrograms | TC21393 |